META-ANALYSIS ON THE RISK OF MALARIA AND RESISTANCE TO ARTEMISININ-BASED COMBINATION THERAPIES (ACTS)
Abstract
Global efforts to control and eradicate malaria are seriously threatened by the rising incidence of drug resistance among malaria parasites, especially resistance to Artemisinin-Based Combination Therapies (ACTs). With an emphasis on clarifying the patterns, trends, and treatment strategy implications, this dissertation conducts a thorough meta-analysis to assess the risk variables for malaria and ACT resistance. To offer solid statistical insights into the occurrence of resistance and its correlation with other factors, such as geographic location, treatment methods, and parasite genetics, this study synthesizes data from the body of current literature. This research adopts a systematic approach, using a random-effects meta-analysis framework to aggregate findings from peer-reviewed studies conducted between 2002 and 2024. Key outcomes include the pooled prevalence of ACT resistance and the estimated effect sizes of contributing risk factors, such as treatment delays, monotherapy use, and suboptimal adherence to ACT regimens. The analysis revealed a significant increase in malaria risk in populations with reported ACT resistance, with a mean effect size of 1.432 (95% CI: 1.193–1.720, P < 0.001). Substantial heterogeneity was observed among the studies, as indicated by an I² value of 90%.” The results indicate significant regional variation in resistance patterns, with Southeast Asia and parts of Africa showing higher prevalence rates linked to the presence of Plasmodium falciparum mutations, particularly in the kelch13 gene. The results emphasize the urgency of targeted interventions—like better monitoring systems, better diagnostic tools, and compliance with combination therapy guidelines—are needed. To properly modify treatment plans, this study highlights the cruciality of combining genetic surveillance with clinical and epidemiological data. To reduce the likelihood of ACT resistance and preserve the effectiveness of frontline malaria treatments, this dissertation offers researchers, policymakers, and medical professionals’ practical’ insights. Through its rigorous methodological approach and comprehensive analysis, this study contributes to the growing body of evidence on the challenges posed by malaria drug resistance and underscores the urgency of collaborative global efforts to address this public health crisis.
Keywords:
Malaria, Artemisinin-Based Combination Therapies, drug resistance, meta-analysis, Plasmodium falciparum, public health strategies.Downloads
Published
DOI:
https://doi.org/10.5281/zenodo.14719035Issue
Section
How to Cite
License
Copyright (c) 2025 Adehi Mary, Ibrahim Ahmed, Majimris Inkab Jatau , Suleiman Ismail
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Amambua-Ngwa, A., Jeffries, D., Amato, R., Worwui, A., Karim, M., Ceesay, S., ... & Conway, D. J. (2019). Consistent signatures of selection from genomic analysis of pairs of temporal and spatial Plasmodium falciparum populations from The Gambia. Scientific Reports, 9(1), 1-13.
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., ... & Smithuis, F. (2014). The spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 371(5), 411-423.
Ashley, E. A., Dhorda, M., Fairhurst, R. M., et al. (2018). The spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 371(5), 411–423.
Beshir, K. B., Sutherland, C. J., Sawa, P., Drakeley, C. J., Okell, L., Mweresa, C. K., ... & Omar, S. A. (2013). Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. The Journal of Infectious Diseases, 208(12), 2017-2024.
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., & Gething, P. W. (2015). Effects of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature, 526(7572), 207-211.)
Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2010). A basic introduction to fixed‐effect and random‐effects models for meta‐analysis. Research Synthesis Methods, 1(2), 97-111.
Cowman, A. F., Healer, J., Marapana, D., et al. (2016). Malaria: Biology and disease. Cell, 167(3), 610–624.
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177-188.
Dondorp, A. M., F. Nosten, P. Yi, et al. (2017). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361(5), 455–467.
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P., Socheat, D., ... & White, N. J. (2009). Artemisinin resistance: current status and scenarios for containment. Nature Reviews Microbiology, 7(12), 810-818.
Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455-463.
Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629-634.
Fairhurst, R. M. (2015). Understanding artemisinin-resistant malaria: what a difference a year makes. Current Opinion in Infectious Diseases, 28(5), 417-425.
Fidock, D. A. (2013). Drug discovery: Priming the antimalarial pipeline. Nature, 504(7479), S9–S11.
Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., ... & Su, X. Z. (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence of its role in chloroquine resistance. Molecular Cell, 6(4), 861-871.
Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., ... & Sterne, J. A. (2011). The Cochrane Collaboration' s tool for assessing risk of bias in randomized trials. BMJ, 343, d5928.
Higgins, J. P., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (Eds.). (2021). Cochrane handbook for systematic reviews of interventions. John Wiley & Sons.
Higgins, J. P., Thompson, S. G., Deeks, J. J., and Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557-560.
Imwong, M., Hien, T. T., Thuy-Nhien, N. T., Dondorp, A. M., & White, N. J. (2017). Spread of the single multidrug-resistant malaria parasite lineage (PfPailin) to Vietnam. The Lancet Infectious Diseases, 17(10), 1022-1023.)
Imwong, M., Suwannasin, K., Kunasol, C., Sutawong, K., Mayxay, M., Rekol, H., & Tun, K. M. (2017). The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study. The Lancet Infectious Diseases, 17(5), 491-497.
Leang, R., Barrette, A., Bouth, D. M., Menard, D., Abdur, R., Duong, S., ... & Ringwald, P. (2013). Efficacy of dihydroartemisinin–piperaquine for treating uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrobial agents and chemotherapy, 57(2), 818-826.
MalariaGEN Consortium. (2020). Insights into malaria susceptibility using genome-wide data of 17,000 individuals from Africa, Asia and Oceania. Nature Communications, 11(1), 1-15.
Ménard, D., & Dondorp, A. (2017). Anti-malarial drug resistance: a threat to malaria elimination. Cold Spring Harbor perspectives in medicine, 7(7), pp. a025619.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6(7), e1000097.
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ... Anderson, T. J. (2012). Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. The Lancet, 379(9830), 1960-1966.
Ranson, H., and N. Lissenden (2016). Insecticide resistance in African Anopheles mosquitoes: a worsening situation that requires urgent action to maintain malaria control. Trends in parasitology, 32(3), 187-196.
Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, & Anderson, T. (2009). Intercontinental spread of pyrimethamine-resistant malaria. Science, 305(5687), 1124.
Takala-Harrison, S., Jacob, C. G., Arze, C., Cummings, M. P., Silva, J. C., Dondorp, A. M., ... & Amaratunga, C. (2015). Independent emergence of artemisinin resistance mutations in Plasmodium falciparum in Southeast Asia. The Journal of Infectious Diseases, 211(5), 670-679.
Trape, J. F. (2001). The public health impact of chloroquine resistance in Africa. The American journal of tropical medicine and hygiene, 64(1_suppl), 12-17.)
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., ... & Higgins, J. P. (2016). ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ 2016; 355: i4919.
Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Altman, D. G. (2019). RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ, 2019; 366: l4898.
Uwimana, A., Legrand, E., Stokes, B. H., Ndikumana, J. L. M., Warsame, M., Umulisa, N., ... Wong, W. (2020). Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nature Medicine, 26(10), 1602-1608.
Van Hong, N., Amambua-Ngwa, A., Tuan Ngo, T., Cuong Do Manh, N., Cuong, D. D., Van Duyet, L., ... & Nhan, H. T. (2020). Genomics analysis to track artemisinin resistance in the Greater Mekong Subregion. Infection, Genetics and Evolution, 78, 104120.
Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2020). The Newcastle-Ottawa scale (NOS) was used to assess the quality of nonrandomized studies in meta-analyses. Retrieved from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
World Health Organization. (2020). World Malaria Report 2020. Geneva, Switzerland: World Health Organization.
WHO. (2015). Global report on anti-malarial drug efficacy and drug resistance: 2000-2010. Geneva, Switzerland: World Health Organization.
WHO. (2020). Guidelines for the treatment of malaria. Geneva: World Health Organization.
World Health Organization. (2020). Malaria fact sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/malaria
WHO. (2020). World malaria report 2020. Geneva, Switzerland: World Health Organization.
